What can be achieved with an HIV vaccine

作者: Jay A Levy

DOI: 10.1016/S0140-6736(00)03601-1

关键词: Viral diseaseImmunologyVaccinationImmunityHIV vaccineDiseasePopulationVirologyVirusMedicineAcquired immunodeficiency syndrome (AIDS)

摘要: For years scientists have searched for ways to develop an effective HIV vaccine. However all attempts at showing the efficacy of vaccine in animals not indicated any clear-cut correlate protection; and most laboratory prevention infection was recorded. On other hand studies show evidence alternative approach development. This indicates that a reasonable should be directed but control spread development clinically apparent disease. It is noted since existing approaches viruses are almost always associated with some replication agent would probably also find way easily establish itself cells vaccinated host. will hopefully stimulate immune system maintain this virus. Thus pathogenesis could prevented or least delayed long time by Importantly ensure rapid virus worldwide suppressed epidemic contained. direction achievement successful considered discussions on future infections AIDS.

参考文章(17)
Susan A Fiscus, Adaora A Adimora, Victor J Schoenbach, Wilma Lim, Ross McKinney, David Rupar, Jean Kenny, Charles Woods, Catherine Wilfert, Perinatal HIV Infection and the Effect of Zidovudine Therapy on Transmission in Rural and Urban Counties JAMA: The Journal of the American Medical Association. ,vol. 275, pp. 1483- 1488 ,(1996) , 10.1001/JAMA.1996.03530430027034
A. Fogel, Ch.B. Gerichter, B. Barnea, R. Handsher, E. Heeger, Response to experimental challenge in persons immunized with different rubella vaccines The Journal of Pediatrics. ,vol. 92, pp. 26- 29 ,(1978) , 10.1016/S0022-3476(78)80064-X
Jeanette Wilkins, Reinfection With Rubella Virus Despite Live Vaccine Induced Immunity American Journal of Diseases of Children. ,vol. 118, pp. 275- 294 ,(1969) , 10.1001/ARCHPEDI.1969.02100040277025
I.R. Pedersen, C.H. Mordhorst, G. Glikmann, H. von Magnus, Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland Vaccine. ,vol. 7, pp. 345- 348 ,(1989) , 10.1016/0264-410X(89)90199-0
Gene M. Shearer, Mario Clerici, Protective immunity against HIV infection: has nature done the experiment for us? Immunology Today. ,vol. 17, pp. 21- 24 ,(1996) , 10.1016/0167-5699(96)80564-0
Gillian C. Harcourt, Jennifer M. Best, J. E. Banatvala, Rubella-Specific Serum and Nasopharyngeal Antibodies in Volunteers with Naturally Acquired and Vaccine-Induced Immunity after Intranasal Challenge The Journal of Infectious Diseases. ,vol. 142, pp. 145- 155 ,(1980) , 10.1093/INFDIS/142.2.145
Sarah L Rowland-Jones, Andrew McMichael, None, Immune responses in HIV-exposed seronegatives: have they repelled the virus? Current Opinion in Immunology. ,vol. 7, pp. 448- 455 ,(1995) , 10.1016/0952-7915(95)80087-5
Stephen C. Hadler, Donald P. Francis, James E. Maynard, Sumner E. Thompson, Franklyn N. Judson, Dean F. Echenberg, David G. Ostrow, Paul M. O'Malley, Kent A. Penley, Norman L. Altman, Erwin Braff, Gregory F. Shipman, Patrick J. Coleman, Eric J. Mandel, Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men The New England Journal of Medicine. ,vol. 315, pp. 209- 214 ,(1986) , 10.1056/NEJM198607243150401